Central Trust CO Alaunos Therapeutics, Inc. Transaction History

Central Trust CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 08, 2019	SELL	$1.61 - $3.62 $821 - $1,846	-510 Closed	0 $0
Q4 2017 Jan 23, 2018	SELL	$4.0 - $6.54 $12,000 - $19,620	-3,000 Reduced 85.47%	510 $0
Q3 2017 Oct 17, 2017	BUY	$4.99 - $6.57 $17,514 - $23,060	3,510	3,510 $0

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Trust CO with notifications on news.